Buy or sell Element Biosciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Element Biosciences Stock

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.

About Element Biosciences Stock

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high quality data, workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improve the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality.

Funding History

June 2019$15.0M
January 2020$80.0M
June 2020$30.0M
June 2021$276M

Management

CEO

Molly He

CTO & Co-Founder

Michael Previte

Chairman

John Stuelpnagel

Vice President Finance

Logan Zinser

Board Member

Jim Tananbaum

Co-Founder

Matt Kellinger

Vice President, Human Capital Management

Steve Potter

Board Member

Bryan Roberts

Senior Vice President Of Engineering

Francisco Garcia

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo